Holbrook Kerr 4
4 · AVANOS MEDICAL, INC. · Filed Mar 6, 2025
Insider Transaction Report
Form 4
Holbrook Kerr
SVP, Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-03-04+5,145→ 92,393 total - Tax Payment
Common Stock
2025-03-04$15.13/sh−1,803$27,279→ 90,590 total - Tax Payment
Common Stock
2025-03-04$15.13/sh−1,543$23,346→ 89,047 total
Footnotes (4)
- [F1]Represents performance-based restricted share units (PRSUs) which: (i) were awarded to the Reporting Person on March 4, 2022 and (ii) vested on March 4, 2025. Each PRSU is the economic eqiuvalent of one share of Common Stock.
- [F2]Total beneficially owned includes 117 shares acquired on December 31, 2024 and 1,000 shares acquired on June 30, 2024 under the Issuer's Employee Stock Purchase Plan.
- [F3]Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 5,145 PRSUs which vested on March 4, 2025.
- [F4]Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 4,403 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 4, 2022 and (ii) vested on March 4, 2025. Each TRSU is the economic equivalent of one share of Common Stock.